Positive Outcomes of a Proactive Iron Deficiency Anemia Program in Saudi Arabia

Purpose: Iron deficiency anemia is a prevalent health concern globally, impacting a significant portion of women and children worldwide, as estimated by the WHO to be 41% and 27%, respectively. This global concern is mirrored in Saudi Arabia, where IDA is particularly prevalent among infants and children. The implications of IDA are far-reaching, potentially leading to severe consequences such as suboptimal mental and motor development in young children, increased risk of maternal mortality, and decreased economic productivity in adults. Therefore, understanding the prevalence and risk factors associated with IDA is crucial not only for effective treatment but also for the development of robust prevention strategies. Recent studies in Saudi Arabia have underscored the urgency of this issue, revealing a high prevalence of IDA in infants aged 6-24 months. Materials and Methods: This study employed a retrospective data analysis approach to identify and proactively manage adult patients with iron deficiency anemia. Data were extracted from the hospital's electronic health records system, VIDA, focusing on outpatients meeting specific criteria. Findings: Over a six-month period in 2023, a 665 patients were identified as potentially eligible for the proactive IDA management program, 80 % were females and 20 % are males on the bases of the pre-defined criteria. A 30 % of these nominated cases successfully secured appointments within the family medicine clinics and subsequently received appropriate treatment for their iron deficiency anemia. This indicates the program's effectiveness in facilitating access to care for a notable portion of the identified patient population. Unique Contribution to Theory, Practice and Policy: Our program enhances the theoretical understanding of integrated care models for chronic disease management. This program introduces a novel, practical approach to IV iron therapy delivery. The success of this program provides a strong case for the development and implementation of similar rapid-access anemia and IV iron services within healthcare systems.